3

OWNERSHIP DOCUMENT

Company: Actinium Pharmaceuticals, Inc.
Filed: May 17, 2017
Period of Report: May 15, 2017
Accession Number: 0001213900-17-005422

View Document ↗ View on SEC.gov ↗